AnnouncementsParenteral Drugs India: Outcome of board meeting
AnnouncementsParenteral Drugs India: Board meeting on Oct 30, 2013
|Company Name||Last Price||%
|Dr Reddys Labs||2421.95||0.36||2545.00||1764.00||41,197.31|
|Jun' 13||Mar' 13||Dec' 12||Sep' 12|
|No Mutual Funds Holding the share|
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 120.16 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.
The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director.
It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.
Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.
Their Registrars are Link Intime India Pvt. Ltd.